Phibro Animal Health (PAHC) Long-Term Deferred Tax (2019 - 2026)

Phibro Animal Health has reported Long-Term Deferred Tax for 8 years, with the latest figure at $17.0 million in Q2 2026.

• On a quarterly basis, Long-Term Deferred Tax fell 33.42% year-over-year to $17.0 million in Q2 2026; TTM through Jun 2026 was $17.0 million, a 33.42% decrease from a year earlier, with the FY2026 full-year figure at $17.0 million, down 33.42% from the prior year.
• Long-Term Deferred Tax was $17.0 million for Q2 2026 at Phibro Animal Health, up from $15.3 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $36.2 million in Q1 2025, with the low at $4.1 million in Q1 2022.
• Average Long-Term Deferred Tax over 5 years is $16.1 million, with a median of $14.9 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2026: Long-Term Deferred Tax jumped 184.22% in 2024, then plunged 57.8% in 2026.
• Over 5 years, Long-Term Deferred Tax stood at $6.3 million in 2022, then jumped by 123.91% to $14.1 million in 2023, then surged by 139.16% to $33.8 million in 2024, then slumped by 42.29% to $19.5 million in 2025, then slipped by 12.78% to $17.0 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $17.0 million (Q2 2026), $15.3 million (Q1 2026), and $19.5 million (Q4 2025), per Business Quant data.